AzTrials
AzTrials

AnxietyNCT06300255

Evaluation of the H.O.O.V.E.S. Healing Intensives Program

An observational study of Anxiety and PTSD, run by VA Salt Lake City Health Care System at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to measure the impact of these H.O.O.V.E.S. healing intensives on Veteran participants using several psychological instruments. The investigators are planning to administer the demographic questionnaires and psychological instruments to Veteran participants before the healing intensives. Read more about this study

Who is it for?
Ages 18 to 120 yearsHealthy volunteers can take part
Conditions the study is for
Anxiety, PTSD, Depression
What is being tested?
H.O.O.V.E.S. Healing Intensives
How many people
250 participants
Where
1 siteUnited States
Study dates
24 Apr 2024to 1 Feb 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 120 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Veterans enrolled in a H.O.O.V.E.S. healing intensives program and must have served in the military.

Who may be able to join

  • Veterans who have served in the military
  • Must be enrolled in a H.O.O.V.E.S. Healing Intensives Program
  • English speakers

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • George E. Wahlen Department of Veterans Affairs Medical Center

    Salt Lake City, Utah, 84148

    William Marchand, MD, 801-582-1565 ext. 1847, william.marchand@va.gov

    Recruiting

Other trials in United States

About this study

The aim of this study is to measure the impact of these H.O.O.V.E.S. healing intensives on Veteran participants using several psychological instruments. The investigators are planning to administer the demographic questionnaires and psychological instruments to Veteran participants before the healing intensives. Psychological instruments will be administered immediately pre-intervention, pre- and post-session for each session, post-intervention, 90, 120 and 360 days post-intervention. The primary aim is to assess for statistically significant changes pre- to post session and pre- to post-intervention.

Conditions
Anxiety, PTSD, Depression
Being tested
H.O.O.V.E.S. Healing Intensives
Keywords
Horses, Anxiety, PTSD, Depression
Medical subject headings
Anxiety Disorders, Stress Disorders, Post-Traumatic, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • H.O.O.V.E.S. Healing IntensivesBehavioural

    "H.O.O.V.E.S. is a private, donor-supported charity dedicated to providing fully-funded, [4]-day, non-clinical healing intensives for veterans, their families and caregivers, and first responders across the nation who are seeking recovery from service-connected stress." 1

    References

    1. Home. HOOVES for Vets. Accessed January 24, 2024. https://www.hooves.us/.
Study groups in NCT06300255
Study groupRoleWhat they receive
H.O.O.V.E.S. Healing Intensives ParticipantsVeterans enrolled in a H.O.O.V.E.S. healing intensives program and must have served in the military.
Receives: Behavioral: H.O.O.V.E.S. Healing Intensives

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean Difference in AAQII pre- to post-session and pre- to post-intervention

    AAQII is a 10-item measure that assesses psychological flexibility, with higher values indicating greater psychological inflexibility. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Measured: through study completion, an average of 5 years

  2. Mean Difference in PANAS pre- to post-session and pre- to post-intervention

    PANAS measures short-term positive and negative emotions. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Measured: through study completion, an average of 5 years

  3. Mean Difference in STAI pre- to post-session and pre- to post-intervention

    The STAI tracks the symptoms of anxiety, and the total score ranges from 20 to 80. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Measured: through study completion, an average of 5 years

  4. Mean Difference in PCL pre- to post-session and pre- to post-intervention

    PCL measures PTSD symptoms. The total PCL score can range from 17 to 85, with higher values indicating greater PTSD symptoms. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Measured: through study completion, an average of 5 years

  5. Mean Difference in BDI pre- to post-session and pre- to post-intervention

    The Beck Depression Inventory (BDI) measures depressive symptoms, with higher values indicating greater depressive symptoms. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Measured: through study completion, an average of 5 years

  6. Mean Difference in PTGI pre- to post-session and pre- to post-intervention

    The Post-Traumatic Growth Inventory (PTGI) examines the post-trauma growth using 21 items. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Measured: through study completion, an average of 5 years

  7. Mean Difference in B-SCS pre- to post-session and pre- to post-intervention

    The Brief Suicide Cognitions Scale (B-SCS) assesses the suicide risk. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Measured: through study completion, an average of 5 years

Secondary outcomes (3)
  1. Mean Difference in AAQII pre- to post-session

    AAQII is a 10-item measure that assesses psychological flexibility, with higher values indicating greater psychological inflexibility. The aim is to assess for statistically significant changes between post sessions using the repeated measure ANOVA.

    Measured: through study completion, an average of 5 years

  2. Mean Difference in PANAS pre- to post-session

    PANAS measures short-term positive and negative emotions. The aim is to assess for statistically significant changes between post sessions using the repeated measure ANOVA.

    Measured: through study completion, an average of 5 years

  3. Mean Difference in STAI pre- to post-session

    The STAI tracks the symptoms of anxiety, and the total score ranges from 20 to 80. The aim is to assess for statistically significant changes between post sessions using the repeated measure ANOVA.

    Measured: through study completion, an average of 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Mar 2024
  2. Study start24 Apr 2024
  3. Primary completion1 Feb 2029 (estimated)
  4. Study completion1 Feb 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06300255
Sponsor's protocol ID
IRB 00166616
Status last verified
May 2024
First submitted
27 Feb 2024
Last updated
28 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anxiety and PTSD, run by VA Salt Lake City Health Care System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact William Marchand, MD (801-582-1565 ext. 1847, william.marchand@va.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean Difference in AAQII pre- to post-session and pre- to post-intervention (time frame: through study completion, an average of 5 years). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in